Advertisement
Singapore markets open in 43 minutes
  • Straits Times Index

    3,343.35
    +11.65 (+0.35%)
     
  • S&P 500

    5,482.87
    +4.97 (+0.09%)
     
  • Dow

    39,164.06
    +36.26 (+0.09%)
     
  • Nasdaq

    17,858.68
    +53.53 (+0.30%)
     
  • Bitcoin USD

    61,602.44
    +832.12 (+1.37%)
     
  • CMC Crypto 200

    1,284.17
    +18.03 (+1.42%)
     
  • FTSE 100

    8,179.68
    -45.65 (-0.55%)
     
  • Gold

    2,338.50
    +1.90 (+0.08%)
     
  • Crude Oil

    82.06
    +0.32 (+0.39%)
     
  • 10-Yr Bond

    4.2880
    -0.0280 (-0.65%)
     
  • Nikkei

    39,341.54
    0.00 (0.00%)
     
  • Hang Seng

    17,716.47
    -373.46 (-2.06%)
     
  • FTSE Bursa Malaysia

    1,584.94
    -6.01 (-0.38%)
     
  • Jakarta Composite Index

    6,967.95
    -6,905.64 (-49.78%)
     
  • PSE Index

    6,390.58
    +77.47 (+1.23%)
     

Basler Leads Trio Of Stocks Estimated To Be Trading Below Fair Value On German Exchange

Amidst a challenging week for European markets, characterized by political uncertainties and volatile bond yields, investors are navigating cautiously. In such an environment, identifying stocks that appear undervalued relative to their fundamentals could offer potential opportunities for discerning investors.

Top 10 Undervalued Stocks Based On Cash Flows In Germany

Name

Current Price

Fair Value (Est)

Discount (Est)

Kontron (XTRA:SANT)

€20.24

€31.45

35.6%

SAP (XTRA:SAP)

€175.76

€281.90

37.7%

MTU Aero Engines (XTRA:MTX)

€225.00

€399.53

43.7%

Stratec (XTRA:SBS)

€47.00

€80.11

41.3%

SBF (DB:CY1K)

€2.76

€5.25

47.4%

CHAPTERS Group (XTRA:CHG)

€23.80

€44.35

46.3%

GIEAG Immobilien (MUN:2GI)

€2.30

€4.44

48.2%

Redcare Pharmacy (XTRA:RDC)

€111.90

€197.69

43.4%

Your Family Entertainment (DB:RTV)

€2.40

€4.09

41.3%

Dr. Hönle (XTRA:HNL)

€19.85

€33.18

40.2%

Click here to see the full list of 31 stocks from our Undervalued German Stocks Based On Cash Flows screener.

ADVERTISEMENT

We'll examine a selection from our screener results

Basler

Overview: Basler Aktiengesellschaft specializes in developing, manufacturing, and selling digital cameras for professional users globally, with a market capitalization of approximately €0.36 billion.

Operations: The company generates €190.30 million from its camera segment.

Estimated Discount To Fair Value: 18.1%

Basler, despite recent financial setbacks with a reported significant decline in year-over-year sales and shifting from net income to a net loss, shows potential underpinned by strong future growth expectations. Analysts forecast an 84.03% earnings growth per year, positioning it for profitability within three years. Currently trading at €11.64, below the estimated fair value of €14.22, Basler presents an opportunity as it is undervalued based on cash flow analysis but faces challenges in achieving high return on equity.

XTRA:BSL Discounted Cash Flow as at Jun 2024
XTRA:BSL Discounted Cash Flow as at Jun 2024

CHAPTERS Group

Overview: CHAPTERS Group AG operates in the DACH region, offering software solutions through its subsidiaries, with a market capitalization of approximately €0.43 billion.

Operations: The company generates revenue primarily from data processing, contributing €70.77 million.

Estimated Discount To Fair Value: 46.3%

CHAPTERS Group AG, with a recent revenue jump from €42.07 million to €70.77 million, shows promising growth, outpacing the German market significantly. Despite a net loss reduction to €4.08 million from €5.89 million, profitability is expected within three years. The stock is currently undervalued by over 20%, trading at €23.8 against a fair value of €44.35, based on DCF analysis. However, shareholder dilution occurred last year and return on equity is projected to be low at 13%.

XTRA:CHG Discounted Cash Flow as at Jun 2024
XTRA:CHG Discounted Cash Flow as at Jun 2024

Stratec

Overview: Stratec SE operates globally, designing and manufacturing automation and instrumentation solutions for in-vitro diagnostics and life sciences, with a market cap of approximately €0.57 billion.

Operations: The company generates its revenue from designing and manufacturing solutions for diagnostics and life sciences across various global markets.

Estimated Discount To Fair Value: 41.3%

Stratec SE, despite a recent downturn in net income and sales, remains a compelling case for undervalued stocks based on cash flows. Currently trading at €47, well below the estimated fair value of €80.11, it offers significant upside potential. The company's earnings are expected to grow by 22% annually over the next three years, outpacing the German market forecast of 18.7%. However, its debt is poorly covered by operating cash flow and return on equity is projected to remain low at 11.1%.

XTRA:SBS Discounted Cash Flow as at Jun 2024
XTRA:SBS Discounted Cash Flow as at Jun 2024

Where To Now?

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include XTRA:BSL XTRA:CHG and XTRA:SBS.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com